Wells Fargo’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.34K | Hold |
|
|||||
|
2025
Q1 | $5.65K | Hold |
|
|||||
|
2024
Q4 | $12.7K | Sell |
|
|||||
|
2024
Q3 | $10.2K | Buy |
|
|||||
|
2024
Q2 | $2.68K | Sell |
|
|||||
|
2024
Q1 | $27.8K | Buy |
|
|||||
|
2023
Q4 | $18.1K | Sell |
|
|||||
|
2023
Q3 | $53.6K | Sell |
|
|||||
|
2023
Q2 | $79.7K | Sell |
|
|||||
|
2023
Q1 | $359K | Buy |
|
|||||
|
2022
Q4 | $41.8K | Sell |
|
|||||
|
2022
Q3 | $70K | Sell |
|
|||||
|
2022
Q2 | $246K | Buy |
|
|||||
|
2022
Q1 | $211K | Sell |
|
|||||
|
2021
Q4 | $837K | Sell |
|
|||||
|
2021
Q3 | $1.01M | Sell |
|
|||||
|
2021
Q2 | $2.44M | Sell |
|
|||||
|
2021
Q1 | $2.55M | Sell |
|
|||||
|
2020
Q4 | $3.89M | Buy |
|
|||||
|
2020
Q3 | $2.3M | Sell |
|
|||||
|
2020
Q2 | $2.6M | Buy |
|
|||||
|
2020
Q1 | $462K | Sell |
|
|||||
|
2019
Q4 | $1.69M | Sell |
|
|||||
|
2019
Q3 | $1.53M | Buy |
|
|||||
|
2019
Q2 | $2.05M | Buy |
|
|||||
|
2019
Q1 | $3.8M | Buy |
|
|||||
|
2018
Q4 | $3.22M | Buy |
|
|||||
|
2018
Q3 | $3.73M | Sell |
|
|||||
|
2018
Q2 | $14.2M | Buy |
|
|||||
|
2018
Q1 | $2.12M | Buy |
|
|||||
|
2017
Q4 | $825K | Sell |
|
|||||
|
2017
Q3 | $912K | Sell |
|
|||||
|
2017
Q2 | $796K | Sell |
|
|||||
|
2017
Q1 | $1.2M | Buy |
|
|||||
|
2016
Q4 | $759K | Buy |
|
|||||
|
2016
Q3 | $764K | Sell |
|
|||||
|
2016
Q2 | $830K | Buy |
|
|||||
|
2016
Q1 | $610K | Buy |
|
|||||
|
2015
Q4 | $832K | Buy |
|
|||||
|
2015
Q3 | $682K | Buy |
|
|||||
|
2015
Q2 | $157K | Buy |
|
|||||
|
2015
Q1 | $42K | Buy |
|
|||||
|
2014
Q4 | $16K | Buy |
|